Goldman Sachs Group Inc Seelos Therapeutics, Inc. Transaction History

Goldman Sachs Group Inc

  • $580 Billion
  • Q2 2024

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

May 14, 2024
SELL
$0.66 - $1.22 $221 - $408
-335 Reduced 1.64%
20,103 $24,000
Q2 2023

Aug 14, 2023
SELL
$0.66 - $1.22 $221 - $408
-335 Reduced 1.64%
20,103 $24,000
Q1 2023

May 14, 2024
SELL
$0.59 - $1.04 $386 - $681
-655 Reduced 3.11%
20,438 $14,000
Q1 2023

May 11, 2023
SELL
$0.59 - $1.04 $386 - $681
-655 Reduced 3.11%
20,438 $14,000
Q4 2022

May 14, 2024
SELL
$0.66 - $259.46 $1,920 - $755,028
-2,910 Reduced 12.12%
21,093 $14,000
Q4 2022

Feb 13, 2023
SELL
$0.66 - $259.46 $1,920 - $755,028
-2,910 Reduced 12.12%
21,093 $14,000
Q3 2022

May 14, 2024
SELL
$0.65 - $278.68 $82,765 - $35.5 Million
-127,332 Reduced 84.14%
24,003 $25,000
Q3 2022

Nov 10, 2022
SELL
$0.65 - $278.68 $82,765 - $35.5 Million
-127,332 Reduced 84.14%
24,003 $0
Q2 2022

May 14, 2024
BUY
$0.51 - $0.93 $77,180 - $140,741
151,335 New
151,335 $103,000
Q2 2022

Aug 15, 2022
BUY
$0.51 - $0.93 $10,060 - $18,345
19,726 Added 14.99%
151,335 $103,000
Q1 2022

May 16, 2022
SELL
$0.84 - $1.71 $21,188 - $43,133
-25,224 Reduced 16.08%
131,609 $110,000
Q4 2021

Feb 14, 2022
BUY
$1.59 - $2.38 $94,108 - $140,867
59,188 Added 60.62%
156,833 $255,000
Q3 2021

Nov 10, 2021
BUY
$1.69 - $2.89 $165,020 - $282,194
97,645 New
97,645 $235,000

Others Institutions Holding SEEL

# of Institutions
1
Shares Held
40.5K
Call Options Held
0
Put Options Held
0
View Full List

About SEELOS THERAPEUTICS, INC.

SEEL Quotes by TradingView
  • Ticker SEEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 106,691,000
  • Market Cap $117M
  • Description
  • Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...
More about SEEL
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email